Functional Genomics of Rare Genetic Diseases: Realization of Innovative Tools With High Diagnostic Power
NCT ID: NCT04152876
Last Updated: 2019-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2019-10-31
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be conducted through the application of complementary experimental strategies, ranging from the clinical, genetic and molecular characterization of the pathology to the search for rare variants and the development of cellular disease models.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genomic Profiling of Genetic and Rare Diseases
NCT06926127
PREcision Diagnostics in Rare genetIC Diseases and Tumors - Long Read Sequencing
NCT06796751
Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases
NCT04024774
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
NCT05996731
Identification of the Genetic Causes of Rare Diseases With Negative Exome Findings
NCT04315727
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. High throughput analysis of genetic variants in genome exomes
3. Genotype-phenotype association testing
4. Identification of genetic risk variants for rare diseases
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Patients with rare disease
No interventions assigned to this group
controls
Healthy parents and relatives
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Genetics and Biophysics CNR
UNKNOWN
Neuromed IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diego Centonze
Head of Neurology Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diego Centonze, MD
Role: PRINCIPAL_INVESTIGATOR
Head of Neurology Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Neuromed
Pozzilli, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PON MISE n. F/050011/01/X32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.